Reply to the letter to the editor "Impella device use in high-risk PCI"

被引：1
|
作者：
Khalid, Nauman [1 ]
Rogers, Toby [1 ,2 ]
Shlofmitz, Evan [1 ]
Chen, Yuefeng [1 ]
Waksman, Ron [1 ]
机构：
[1] MedStar Washington Hosp Ctr, Sect Intervent Cardiol, Washington, DC USA
[2] NHLBI, Cardiovasc Branch, Div Intramural Res, NIH, Bldg 10, Bethesda, MD 20892 USA
来源：
EUROINTERVENTION | 2019年 / 15卷 / 08期
关键词：
D O I：
10.4244/EIJ-D-19-00279R
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：732 / 732
页数：1
相关论文
共 50 条
  • [21] Evaluation of LVEDP Change During High-Risk PCI With and Without Impella Support (ELVIS)-A Pilot Trial
    Leick, Juergen
    Gjata, Anida
    Pulz, Jan
    Weisbarth, Tobias
    Richter, Kristof
    Krause, Tobias
    Saad, Louai
    Zayat, Rashad
    Kolat, Philipp
    Haneya, Assad
    Sinning, Jan-Malte
    Werner, Nikos
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (03)
  • [22] Single-access dual-injection technique (SADIT) for high-risk PCI with Impella CP
    Marmagkiolis, Konstantinos
    Caballero, Jaime A.
    Cilingiroglu, Mehmet
    Iliescu, Cezar
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2021, 98 (06) : 1138 - 1140
  • [23] Reply to Letter to the Editor: Best-Available Evidence Supports the Use of Rheopheresis for High-Risk Dry Age-Related Macular Degeneration
    Klingel, Reinhard
    Koch, Frank H. J.
    Kirchhof, Bernd
    THERAPEUTIC APHERESIS AND DIALYSIS, 2010, 14 (06) : 608 - 609
  • [24] Evaluation of LVEDP Change During High-Risk PCI With and Without Impella Support (ELVIS): A Pilot Trial
    Gjata, Anida
    Weisbarth, Tobias
    Richter, Kristof
    Krause, Tobias
    Saad, Louai
    Zayat, Rashad
    Kolat, Philipp
    Haneya, Assad
    Sinning, Jan-Malte
    Werner, Nikos
    Leick, Juergen
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (18) : B213 - B214
  • [25] An unexpected complication after impella use for high-risk percutaneous coronary intervention
    Roccasalva, Fausto
    Cannata, Francesco
    Chiarito, Mauro
    Pellegrino, Marta
    Pagnotta, Paolo
    Lancini, Damiano Regazzoli
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0J) : J105 - J105
  • [26] Letter to the Editor: How Should We Treat High-risk Patients in the Chronic Phase Following PCI: Clopidogrel or Prolonged DAPT?
    Wang, Hao-Yu
    Dou, Ke-Fei
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2021, 36 (22)
  • [27] The Use of the Impella® LP 2.5 Percutaneous Microaxial Ventricular Assist Device as Hemodynamic Support During High-Risk Abdominal Surgery
    Atoui, Rony
    Samoukovic, Gordan
    Al-Tuwaijri, Fahad
    Malas, Tarek
    Giannetti, Nadia
    Barkun, Jeffrey
    Lash, Vynka
    Cecere, Renzo
    JOURNAL OF CARDIAC SURGERY, 2010, 25 (02) : 238 - 240
  • [28] Beneficial Diastolic Effects of Mechanical Left Ventricular Unloading by Impella During High-Risk PCI and Primary PCI for Acute Myocardial Infarction
    Remmelink, Maurice
    Sjauw, Krischan D.
    Henriques, Jose P.
    de Winter, Robbert J.
    van der Schaaf, Rene J.
    Vis, Marije M.
    Koch, Karel T.
    Paulus, Walter J.
    de Mol, Bas A.
    Tijssen, Jan G.
    Piek, Jan J.
    Baan, Jan, Jr.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A56 - A56
  • [29] OUTCOME IN PATIENTS UNDERGOING HIGH-RISK PCI USING IMPELLA CIRCULATORY SUPPORT-10 YEAR EXPERIENCE
    Vetrugno, Vincenzo
    Waqas, Muhammad
    Sandhu, Kulwinder
    Mechery, Anthony
    Nadir, M. Adnan
    George, Sudhakar
    Zaphiriou, Alexander
    Lim, Sern
    Ludman, Peter
    Doshi, Sagar
    Townend, Jonathan
    Khan, Sohail
    HEART, 2019, 105 : A60 - A61
  • [30] Prophylactic Impella CP versus VA-ECMO in Patients Undergoing Complex High-Risk Indicated PCI
    Van Den Buijs, Deborah M. F.
    Wilgenhof, Adriaan
    Knaapen, Paul
    Zivelonghi, Carlo
    Meijers, Tom
    Vermeersch, Paul
    Arslan, Fatih
    Verouden, Niels
    Nap, Alex
    Sjauw, Krischan S.
    Van Den Brink, Floris S.
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2022, 2022
12345